G. Mikael Dolsten's most recent trade in Agilent Technologies Inc. was a trade of 1,600 Common Stock done at an average price of $135.4 . Disclosure was reported to the exchange on May 29, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Agilent Tech | G. Mikael Dolsten | Director | Sale of securities on an exchange or to another person at price $ 135.42 per share. | 29 May 2026 | 1,600 | 5,548 (0%) | 0% | 135.4 | 216,672 | Common Stock |
| Apellis Pharma Inc | G. Mikael Dolsten | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 14 May 2026 | 24,135 | 0 | - | - | Stock Option (right to buy) | |
| Apellis Pharma Inc | G. Mikael Dolsten | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 14 May 2026 | 14,312 | 0 (0%) | 0% | - | Common Stock | |
| Apellis Pharma Inc | G. Mikael Dolsten | Director | 14 May 2026 | 14,312 | 0 (0%) | 0% | - | Common Stock | ||
| Agilent Tech | G. Mikael Dolsten | Director | Grant, award, or other acquisition of securities at price $ 111.75 per share. | 19 Mar 2026 | 2,158 | 7,138 (0%) | 0% | 111.8 | 241,157 | Common Stock |
| Agilent Tech | G. Mikael Dolsten | Director | Sale of securities on an exchange or to another person at price $ 149.81 per share. | 01 Dec 2025 | 2,600 | 4,973 (0%) | 0% | 149.8 | 389,511 | Common Stock |
| Agilent Tech | G. Mikael Dolsten | Director | Grant, award, or other acquisition of securities at price $ 121.18 per share. | 14 Mar 2025 | 1,819 | 7,549 (0%) | 0% | 121.2 | 220,426 | Common Stock |